LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220K954. A total of 3 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,024,632 | +468.5% | 17,100 | +584.0% | 0.00% | +200.0% |
| Q2 2023 | $180,250 | -49.2% | 2,500 | +8.7% | 0.00% | – |
| Q4 2021 | $355,000 | +6.3% | 2,300 | -4.2% | 0.00% | – |
| Q3 2021 | $334,000 | +59.0% | 2,400 | +50.0% | 0.00% | – |
| Q2 2021 | $210,000 | -98.9% | 1,600 | -98.7% | 0.00% | -100.0% |
| Q1 2021 | $18,751,000 | +230.8% | 123,000 | +115.8% | 0.03% | +180.0% |
| Q4 2020 | $5,669,000 | +7.0% | 57,000 | +2.5% | 0.01% | -41.2% |
| Q3 2020 | $5,300,000 | -39.8% | 55,600 | -29.4% | 0.02% | -58.5% |
| Q2 2020 | $8,803,000 | +490.4% | 78,700 | +283.9% | 0.04% | +241.7% |
| Q1 2020 | $1,491,000 | -63.3% | 20,500 | -47.4% | 0.01% | -57.1% |
| Q4 2019 | $4,067,000 | +7.5% | 39,000 | +2.6% | 0.03% | -9.7% |
| Q3 2019 | $3,783,000 | +163.1% | 38,000 | +201.6% | 0.03% | +138.5% |
| Q2 2019 | $1,438,000 | -66.7% | 12,600 | -63.3% | 0.01% | -72.9% |
| Q1 2019 | $4,312,000 | +125.4% | 34,300 | +143.3% | 0.05% | +182.4% |
| Q4 2018 | $1,913,000 | +78.6% | 14,100 | +261.5% | 0.02% | +112.5% |
| Q3 2018 | $1,071,000 | +5000.0% | 3,900 | +3800.0% | 0.01% | – |
| Q2 2018 | $21,000 | -22.2% | 100 | -50.0% | 0.00% | – |
| Q4 2017 | $27,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q3 2017 | $27,000 | -98.7% | 200 | -98.9% | 0.00% | -100.0% |
| Q2 2017 | $2,125,000 | -83.5% | 17,500 | -85.6% | 0.02% | -85.3% |
| Q1 2017 | $12,849,000 | +99.5% | 121,400 | +91.5% | 0.15% | +141.9% |
| Q4 2016 | $6,442,000 | +32110.0% | 63,400 | +31600.0% | 0.06% | – |
| Q3 2016 | $20,000 | -97.1% | 200 | -96.6% | 0.00% | -100.0% |
| Q2 2016 | $692,000 | -40.2% | 5,800 | -46.3% | 0.01% | -50.0% |
| Q1 2016 | $1,157,000 | +97.8% | 10,800 | +100.0% | 0.02% | +128.6% |
| Q4 2015 | $585,000 | +42.3% | 5,400 | +12.5% | 0.01% | +16.7% |
| Q3 2015 | $411,000 | -72.7% | 4,800 | -67.8% | 0.01% | -71.4% |
| Q2 2015 | $1,503,000 | +85.6% | 14,900 | +41.9% | 0.02% | +61.5% |
| Q1 2015 | $810,000 | +592.3% | 10,500 | +377.3% | 0.01% | +550.0% |
| Q4 2014 | $117,000 | -51.2% | 2,200 | -56.9% | 0.00% | -50.0% |
| Q3 2014 | $240,000 | -53.6% | 5,100 | -38.6% | 0.00% | -50.0% |
| Q2 2014 | $517,000 | -17.4% | 8,300 | -10.8% | 0.01% | -27.3% |
| Q1 2014 | $626,000 | +5590.9% | 9,300 | +4550.0% | 0.01% | – |
| Q4 2013 | $11,000 | -98.9% | 200 | -99.2% | 0.00% | -100.0% |
| Q3 2013 | $1,021,000 | -31.1% | 23,600 | -40.4% | 0.02% | -45.9% |
| Q2 2013 | $1,482,000 | – | 39,600 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 23,600 | $1,021,000 | 0.02% |